CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 2018—Quidel has received clearance from the FDA to market its Solana respiratory syncytial virus plus human metapneumovirus assay for the detection of nucleic acids isolated from nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection to aid in the diagnosis of RSV and/or hMPV infections. The Solana RSV + hMPV Assay is intended for use only with the Solana instrument.
Quidel, 800-874-1517